Clinical trial
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™
NCT02081690 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™
- Lead sponsor
- Actelion
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 1, 2014
- Completion date
- November 1, 2015
- Enrollment
- 160 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.